Savant Capital’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
20,242
+4,346
+27% +$262K ﹤0.01% 787
2026
Q1
$929K Buy
15,896
+2,067
+15% +$122K ﹤0.01% 655
2025
Q4
$783K Buy
13,829
+997
+8% +$54.4K ﹤0.01% 659
2025
Q3
$681K Buy
12,832
+889
+7% +$48.3K ﹤0.01% 688
2025
Q2
$565K Buy
11,943
+1,058
+10% +$46.9K ﹤0.01% 703
2025
Q1
$450K Buy
10,885
+493
+5% +$19.4K ﹤0.01% 701
2024
Q4
$377K Buy
10,392
+2,456
+31% +$88.7K ﹤0.01% 1000
2024
Q3
$290K Buy
+7,936
New +$284K ﹤0.01% 1103

Other funds holding BTI

Savant Capital's BTI Position: Q2 2026 in Review

Savant Capital increased its British American Tobacco (BTI) stake by 27% in Q2 2026, buying an estimated $262K and bringing the position to 20,242 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Savant Capital first reported a position in BTI in Q3 2024 and has held it in 8 quarters since. 907 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Savant Capital held 20,242 shares of British American Tobacco worth $1.24M as of Q2 2026.
  • Savant Capital bought 4,346 British American Tobacco shares in Q2 2026, an estimated $262K.
  • British American Tobacco made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #787 holding.
  • Savant Capital first reported a position in British American Tobacco in Q3 2024 and has held it in 8 quarters since.
  • 907 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.